- cafead   May 20, 2021 at 11:22: AM
via Roche’s Spark Therapeutics and fellow biotech bluebird bio are both developing gene therapies for blood disorders. Now, the two have found themselves in a legal battle that’s not about their treatments or patents, but, instead, trademarks.
article source
article source